Proactive Investors - Run By Investors For Investors

Zelda Therapeutics' Dr. Stewart Washer discusses medical cannabis achievements

Zelda is also building a pre-clinical research portfolio targeting cancer.
Zelda Therapeutics' Dr. Stewart Washer discusses medical cannabis achievements
Cannabis contains at least 85 types of cannabinoids

Zelda Therapeutics Ltd (ASX: ZLD) has secured exclusive, global access to an extensive set of human data related to medicinal cannabis based formulations and treatment protocols.

This human data has been generated over several years by a California-based group (Aunt Zelda’s) that has a high profile within the U.S. which is also growing internationally.

The company has a deep knowledge of the scientific rationale for certain cannabis-based formulations and protocols to treat a variety of medical conditions.

Zelda has embarked on a program of human clinical trials.

WATCH NOW: Zelda half-year review by Stewart Washer, executive director

Zelda is scheduled to release its financial statements to the ASX on Wednesday 30 August 2017.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full ZLD profile View Profile

Zelda Therapeutics Ltd Timeline

Related Articles

Laboratory testing
October 10 2018
Fifteen patients have been enrolled in the trial being carried out at Children’s Hospital of Philadelphia in the USA.
November 14 2018
Ascent, viaThirty Eight Hemp Corp, will exploit the hemp market via its strategic relationship with AgTech Scientific
A cannabis facility
December 02 2018
The Vancouver-based medicinal cannabis grower’s Queensland facility will be the world's largest greenhouse cannabis operation, covering a 99-acre site

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use